Ladenburg Thalmann analyst Michael J. Higgins upgraded Forte Biosciences Inc. (NASDAQ: FBRX) from Neutral to Buy with a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE